_version_ 1784761477515706368
author Nakaya, Aya
Kondo, Morihiro
Ogura, Eiji
Katayama, Yuki
Yoshino, Eiko
Hozumi, Kazuya
Tago, Saori
Teranishi, Yuko
Minamibashi, Yuki
Harada, Makiko
Kawano, Yuri
Arai, Yuka
Kobayashi, Mika
Kouyama, Airi
Yoshida, Keno
Shimizu, Shozo
Ogura, Kazuma
Iwashita, Katsuaki
author_facet Nakaya, Aya
Kondo, Morihiro
Ogura, Eiji
Katayama, Yuki
Yoshino, Eiko
Hozumi, Kazuya
Tago, Saori
Teranishi, Yuko
Minamibashi, Yuki
Harada, Makiko
Kawano, Yuri
Arai, Yuka
Kobayashi, Mika
Kouyama, Airi
Yoshida, Keno
Shimizu, Shozo
Ogura, Kazuma
Iwashita, Katsuaki
author_sort Nakaya, Aya
collection PubMed
description
format Online
Article
Text
id pubmed-9345654
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-93456542022-08-03 Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir Nakaya, Aya Kondo, Morihiro Ogura, Eiji Katayama, Yuki Yoshino, Eiko Hozumi, Kazuya Tago, Saori Teranishi, Yuko Minamibashi, Yuki Harada, Makiko Kawano, Yuri Arai, Yuka Kobayashi, Mika Kouyama, Airi Yoshida, Keno Shimizu, Shozo Ogura, Kazuma Iwashita, Katsuaki Nefrologia Letter to the Editor Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2022-08-03 /pmc/articles/PMC9345654/ /pubmed/35937587 http://dx.doi.org/10.1016/j.nefro.2022.07.004 Text en © 2022 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Nakaya, Aya
Kondo, Morihiro
Ogura, Eiji
Katayama, Yuki
Yoshino, Eiko
Hozumi, Kazuya
Tago, Saori
Teranishi, Yuko
Minamibashi, Yuki
Harada, Makiko
Kawano, Yuri
Arai, Yuka
Kobayashi, Mika
Kouyama, Airi
Yoshida, Keno
Shimizu, Shozo
Ogura, Kazuma
Iwashita, Katsuaki
Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
title Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
title_full Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
title_fullStr Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
title_full_unstemmed Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
title_short Treatment of patients with COVID-19 on hemodialysis: Efficacy of remdesivir
title_sort treatment of patients with covid-19 on hemodialysis: efficacy of remdesivir
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345654/
https://www.ncbi.nlm.nih.gov/pubmed/35937587
http://dx.doi.org/10.1016/j.nefro.2022.07.004
work_keys_str_mv AT nakayaaya treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT kondomorihiro treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT oguraeiji treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT katayamayuki treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT yoshinoeiko treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT hozumikazuya treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT tagosaori treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT teranishiyuko treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT minamibashiyuki treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT haradamakiko treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT kawanoyuri treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT araiyuka treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT kobayashimika treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT kouyamaairi treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT yoshidakeno treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT shimizushozo treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT ogurakazuma treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT iwashitakatsuaki treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir
AT treatmentofpatientswithcovid19onhemodialysisefficacyofremdesivir